{"database": "lobbying", "table": "lobbying_activities", "rows": [[2633071, "f8c293a9-3cec-4c86-babd-e55028a78712", "Q2", "STONINGTON GLOBAL", 401105189, "SORRENTO THERAPEUTICS, INC.", 2021, "second_quarter", "PHA", "Regulatory approvals and funding for pharmaceutical products and devices", "Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 130000, null, 0, 0, "2021-07-06T13:17:21.127000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2633071"], "units": {}, "query_ms": 0.31301099807024, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}